Alzheimer’s disease (AD) and cognitive decline affect millions of families, and researchers continue to search for ways to prevent or slow these conditions. While much progress has been made, the…

Alzheimer’s disease (AD) remains one of the most studied — yet least fully understood — conditions of our time. While researchers have made progress in uncovering risk factors and potential…

November is recognized as Alzheimer’s Awareness Month — a time dedicated to raising awareness, honoring those impacted, and supporting the more than 6.2 million Americans living with Alzheimer’s disease. Quick…

Focused Ultrasound Therapy Focused ultrasound is an innovative, noninvasive technology with the potential to improve quality of life and reduce the cost of care for individuals with Alzheimer’s disease. This…

Alzheimer’s disease is one of the most misunderstood health conditions, and many myths still circulate about its causes, treatments, and risk factors. Understanding what’s true — and what isn’t —…

The FDA has approved a second drug to treat early-stage Alzheimer’s disease — Kisunla, developed by Eli Lilly. In Alzheimer’s patients, proteins in the brain form plaques and tangles that…

The proportion of ethnic minorities among older adults in the United States is steadily increasing. According to the U.S. Census Bureau, the percentage of elders who are white and non-Hispanic…

A degree of mobility loss is common with aging, but certain conditions can accelerate this process. Alzheimer’s disease and other forms of dementia not only affect memory and thinking but…

Researchers do not yet know the exact cause of Alzheimer’s disease. It is believed to result from a combination of genetic, lifestyle, and environmental factors. Among the environmental factors most…

Research continues to show that inflammation plays a significant role in the development and progression of Alzheimer’s disease (AD). Inflammation in the brain, primarily driven by microglia and astrocytes, can…